Latest News: Proscia Receives FDA 510(k) Clearance For Concentriq AP-DxREAD THE PRESS RELEASE

HNL Lab Medicine announces groundbreaking digital pathology investment

Proscia
By Author Proscia | July 18, 2023

HNL Lab Medicine, a leading multi-regional US-based clinical diagnostics laboratory, has made a groundbreaking investment in digital pathology, having selected solutions from Proscia and Leica Biosystems to establish an advanced digital pathology practice.

Our website uses cookies. By using this site, you agree to its use of cookies.